Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

Massie et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d56e3175589c71d767d4c4 — DOI: https://doi.org/10.1056/nejmoa0805450

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure· 2001 · 3,102 citations
2. Radial artery conduit for coronary revascularization: as good as an internal thoracic artery?· 2007 · 14 citations
3. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure Validation Study: Diagnosis and prognosis· 2006 · 69 citations
4. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol· 2002 · 5,414 citations
5. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective· 1995 · 895 citations